drugset / Trial / NCT02352051
Effects of Atx and Oros-mph on Executive Functions
RandomizedParallel-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate and compare the effects of Atomoxetine(ATX) and osmotic release oral system-methylphenidate (OROS-MPH) therapies on executive functions, activities, treatment response time and adverse effects based on discernible clinical effects in children with combined type attention deficit-hyperactivity disorder (ADHD).
Timeline
- Start
- 2014-02
- Primary completion
- 2014-10
- Completion
- 2014-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atomoxetine | Other / unclassified | 1.2 mg/kg | — |
| Comparator | Methylphenidate | Small molecule | 1 mg/kg | — |